CATALAYER NEWS
Pentixapharm gets FDA clearance for phase 3 hypertension study
Source: Investing.com · 2026-06-09
Full article text is available in the Catalayer news terminal.
MORE FROM INVESTING.COM
Why is Oxford Instruments stock sliding today?
2026-06-09
GDS, Vnet shares jump on China data center funding plan
2026-06-09
European defense stocks slide after Morgan Stanley downgrades sector view
2026-06-09
Citizens initiates Park Electrochemical stock coverage on aerospace growth
2026-06-09
Citi warns KOSPI stock index faces downside risk on elevated positioning
2026-06-09
RELATED ON CATALAYER
Related Topics
Biotech & FDA NewsRELATED MARKETS
Prediction Markets